Effects of Angiotensin-Converting Enzyme Inhibition on Transient Ischemia: The Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) Trial

Journal of the American College of Cardiology

Volumn 42, Issue 12, 2003, Pages 2049-2059

  Pepine, Carl J ^a   Rouleau, Jean Lucien ^b   Annis, Karen ^c   Ducharme, Anique ^d   Ma, Patrick ^e   Lenis, Jacques ^f,g   Davies, Richard ^h   Thadani, Udho ⁱ   Chaitman, Bernard ^j   Haber, Harry E ^c   Freedman, S Ben ^k   Pressler, Milton L ^c   Pitt, Bertram ^l  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c PFIZER INC   (United States)

^d MONTREAL HEART INSTITUTE   (Canada)

^e Heart Health Institute   (Canada)

^f Invascor Clinical Research   (Canada)

^g Centre Hospitalier Pierre Boucher   (Canada)

^h UNIVERSITY OF OTTAWA   (Canada)

ⁱ UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^j SAINT LOUIS UNIVERSITY   (United States)

^k UNIVERSITY OF SYDNEY   (Australia)

^l UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRATE; PLACEBO; QUINAPRIL; STATINE DERIVATIVE;

ADULT; AGED; ANGINA PECTORIS; ANGIONEUROTIC EDEMA; ARTICLE; CAUSE OF DEATH; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; COUGHING; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG ERUPTION; DRUG FATALITY; ELECTROCARDIOGRAM; ENDOTHELIUM CELL; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SIDE EFFECT; THORAX PAIN;

EID: 0347918854     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.07.027     Document Type: Article

References (60)

1. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
2. Pfeffer MA, Braunwald EA, Moyé LA, et al., on behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival And Ventricular Enlargement trial. N Engl J Med 1992;327:699-77.
3. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-91.
4. Yusuf S, Pepine CJ, Garces C, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992;340:1173-8.
5. Yusuf S, Kostis JB, Pitt B. ACE inhibitors for myocardial infarction and unstable angina. Lancet 1993;341:829.
6. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-8.
7. Yusuf S, Sleight P, Pogue J, et al., for the Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53.
8. The PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischemic attack. Lancet 2001;358:1033-41.
9. Mancini GBJ, Henry GC, Macaya C, et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND study (Trial on Reversing ENdothelial Dysfunction). Circulation 1996;94:258-65.
10. Zhuo JL, Froomes P, Casley D, et al. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease. Circulation 1997;96:174-82.
11. 15O]water dobutamine stress positron emission tomography. J Am Coll Cardiol 1999;34:1005-111.
12. Anderson TJ, Elstein E, Haber H, Charbonneau F. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). J Am Coll Cardiol 2000;35:60-6.
13. Bussmann WD, Goerke S, Schneider W, Kaltenbach M. Angiotensin-converting- enzym-hemmer bei angina pectoris. Dtsch Med Wochenschr 1988;113:548-50.
14. Bussmann WD, Wittig RA, Brunner I, Bahrmann H. Angiotensin- konversionsenzym-hemmer zur behandlung der angina pectoris. Dtsch Med Wochenschr 1992;117:603-6.
15. Cleland JGF, Henderson E, McLenachan J, Findlay IN, Dargie HJ. Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure. J Am Coll Cardiol 1991;17:733-9.
16. Daly P, Mettauer B, Rouleau JL, Cousineau D, Burgess JH. Lack of reflex increase in myocardial sympathetic tone after captopril: potential antianginal effect. Circulation 1985;71:317-25.
17. Gasic S, Dudczak R, Korn A, Kleinbloesem C. ACE inhibition with cilazapril improves myocardial perfusion to the ischemic regions during exercise: a pilot study. J Cardiovasc Pharmacol 1990;15:227-32.
18. Gibbs JSR, Crean PA, Mockus L, Wright C, Sutton GS, Fox KM. The variable effects of angiotensin converting enzyme inhibition on myocardial ischemia in chronic stable angina. Br Heart J 1989;62:112-7.
19. Ikram H, Low CJS, Shirlaw TM, et al. Angiotensin converting enzyme inhibition in chronic stable angina: effects on myocardial ischemia and comparison with nifedipine. Br Heart J 1994;71:30-3.
20. Klein WW, Khurmi NS, Eber B, Dusleag J. Effects of benazepril and metoprolol OROS alone and in combination on myocardial ischemia in patients with chronic stable angina. J Am Coll Cardiol 1990;16:948-56.
21. Lai C, Onnis E, Orani E, Pirisi R, Soro A, Cherchi A. Effects of enalapril in normotensive patients with stable effort angina: a double blind, placebo controlled study. Drugs Exp Clin Res 1990;16:299-305.
22. Lai C, Alberti D, Onnis E, et al. Effetto del benazepril, nuovo inhibitore dell'enzima di conversione, nell'angina pectoris da sforzo. Cardiologia 1991;36:785-92.
23. Murohara T, Tayama S, Tabuchi T, et al. Effects of angiotensin- converting enzyme inhibitor alacepril in patients with stable effort angina during chronic isosorbide dinitrate treatment. Am J Cardiol 1996;77:1159-63.
24. Overlack A, Adamczak M, Bachmann W, et al. ACE-inhibition with perindopril in essential hypertensive patients with concomitant diseases. Am J Med 1994;97:126-34.
25. Schneeweiss A, Marmor AT, Rettig-Stürmer G. Anti-ischemic effects of cilazapril in patients with both hypertension and angina pectoris: preliminary report of a pilot study. Cardiology 1991;79:46-8.
26. Steffensen R, Grande P, Madsen JK, Rasmussen S, Haunse S. Short-term effects of captopril on exercise tolerance in patients with chronic stable angina pectoris and normal left ventricular function. Cardiology 1995;86:445-50.
27. Strozzi C, Cocco G, Portaluppi F, et al. Effects of captopril on the physical work capacity of normotensive patients with stable-effort angina pectoris. Cardiology 1987;74:226-8.
28. Strozzi C, Portaluppi F, Cocco G, Urso L. Ergometric evaluation of the effects of enalapril maleate in normotensive patients with stable angina. Clin Cardiol 1988;11:246-9.
29. Thürmann P, Odenthal H-J, Rietbrock N. Converting enzyme inhibition in coronary artery disease: a randomized, placebo controlled trial with benazepril. J Cardiovasc Pharmacol 1991;17:718-23.
30. Tzivoni D, Gottlieb S, Khurmi NS, Medina A, Gavish A, Stern S. Effect of benazepril on myocardial ischaemia in patients with chronic stable angina pectoris. Eur Heart J 1992;13:1129-34.
31. van den Heuvel AF, Dunselman PH, Kingma T, et al. Reduction of exercise-induced myocardial ischemia during add-on treatment with the angiotensin-converting enzyme inhibitor enalapril in patients with normal left ventricular function and optimal beta blockade. J Am Coll Cardiol 2001;37:470-4.
32. Winkelmann BR, Matheis G, Kleist P, Pötter S, Wohltmann D, Kaltenbach M. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease. Coron Artery Dis 1994;5:829-44.
33. Iriarte M, Caso R, Murga N, de Argumedo ML, Sagastagoitia D. Microvascular angina in systemic hypertension: diagnosis and treatment with enalapril. Am J Cardiol 1995;76:31-4D.
34. Kaski JC, Rosano G, Gavrielides S, Chen L. Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina. J Am Coll Cardiol 1994;23:652-7.
35. Motz W, Strauer BE. Improvement of coronary flow reserve after long-term therapy with enalapril. Hypertension 1996;27:1031-8.
36. Kinoshita A, Urata H, Bumpus FM, Hussain A. Measurement of angiotensin I converting enzyme inhibition in the heart. Circ Res 1993;73:51-60.
37. Pepine CJ, Geller NL, Knatterud GL, et al., for the ACIP Investigators. The Asymptomatic Cardiac Ischemia Pilot (ACIP): design of a randomized clinical trial, baseline data and implications for a long-term outcome trial. J Am Coll Cardiol 1994;24:1-10.
38. Allred EN, Bleecker ER, Chaitman BR, et al. Effects of carbon monoxide on myocardial ischemia. Environ Health Perspect 1991;91:89-132.
39. Tamesis B, Stelken A, Byers S, et al. Comparison of the Asymptomatic Cardiac Ischemia Pilot and modified Asymptomatic Cardiac Ischemia Pilot versus Bruce and Cornell exercise protocols. Am J Cardiol 1993;72:715-20.
40. Caralis DG, Wiens G, Shaw L. An off-line digital system for reproducible interpretation of the exercise ECG. J Electrocardiol 1990;23:285-91.
41. Fleiss JL. The Design and Analysis of Clinical Experiments. New York, NY: John Wiley and Sons, 1986:176.
42. O'Brien DC. Procedures for comparing samples with multiple end points. Biometrics 1984;40:1079-87.
43. Zeiher AM, Drexler H, Wollschläger H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991;84:1984-92.
44. Zeiher AM, Drexler H, Saurier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993;92:652-62.
45. Egashira K, Hirooka Y, Kai H, et al. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 1994;89:2519-24.
46. Vane JR, Anggard EE, Botting RM. Regulatory function of the vascular endothelium. N Engl J Med 1990;323:27-36.
47. Zeiher AM, Krause T, Schachinger V, Minners J, Moser E. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation 1995;91:2345-52.
48. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990;81:491-8.
49. Vanhoutte PM. Endothelium and responsiveness of vascular smooth muscle. J Hypertens 1987;5 Suppl 5:115-20S.
50. Hasdai D, Gibbons-RJ, Holmes DR Jr., Higano ST, Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 1997;96:3390-5.
51. Sharaf BL, Williams DO, Miele NJ, et al., for the ACIP Investigators. A detailed angiographic analysis of patients with ambulatory electrocardiographic ischemia: results from the Asymptomatic Cardiac Ischemia Pilot (ACIP) study core angiographic laboratory. J Am Coll Cardiol 1997;29:78-84.
52. Kober L, Torp Pedersen C, Carlsen JE, et al., the Trandolapril Cardiac Evaluation (TRACE) Study Group. A clinical trial of the angiotensin-converting- enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995;333:1670-6.
53. Torp Pedersen C, Kober L, Carlsen J. Angio-converting enzyme inhibition after myocardial infarction: the Trandolapril Cardiac Evaluation Study. Am Heart J 1996;132 Suppl:235-43.
54. Pitt B, Pepine C, O'Neill B, Haber H, Pressler M, Mancini GBJ. Modulation of ACE inhibitor efficacy on coronary endothelial dysfunction by low-density lipoprotein cholesterol (abstr). J Am Coll Cardiol 1997;29 Suppl A:70A.
55. Diet F, Pratt RE, Berry GJ, Momose N, Gibbons GH, Dzau VJ. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 1996;94:2756-67.
56. Lyons D, Webster J, Benjamin N. Effect of enalapril and quinapril on forearm vascular ACE in man. Eur J Clin Pharmacol 1997;51:373-8.
57. Drexler H, Zeiher AM, Meinertz T, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet 1991;338:1546-50.
58. Oosterga M, Voors AA, Pinto YM, et al. Effects of quinapril on clinical outcome after coronary artery bypass grafting: the QUO VADIS study (QUinapril On Vascular Ace and Determinants of ISchemia). Am J Cardiol 2001;87:542-6.
59. Fox KM, Henderson JR, Bertrand ME, Ferrari R, Remme WJ, Simoons ML. The European trial on reduction of cardiac events with perindopril in stable coronary artery disease (EUROPA). Eur Heart J 1998;19 Suppl J:J52-5.
60. Pfeffer MA, Domanski M, Rosenberg Y, et al. Prevention of Events with Angiotensin-Converting Enzyme inhibition (the PEACE study design). Am J Cardiol 1998;82:25-30H.